The design and exogenous delivery of siRNA for post-transcriptional gene silencing

Journal of Drug Targeting

Volumn 12, Issue 6, 2004, Pages 315-340

  Gilmore, Ian R ^a   Fox, Stephen P ^a   Hollins, Andrew J ^a   Sohail, Muhammad ^b   Akhtar, Saghir ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Delivery; Dendrimer; Design; Liposomes; Polymer; RNAi; Small interfering RNA; Vectors

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ANTISENSE OLIGONUCLEOTIDE; CALCIUM PHOSPHATE; DENDRIMER; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DOUBLE STRANDED RNA; HETERODUPLEX; LIPOFECTAMINE; LIPOFECTIN; LIPOSOME; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OLIGONUCLEOTIDE; PEPTIDE NUCLEIC ACID; PLASMID DNA; POLYAMINE DERIVATIVE; POLYANION; POLYETHYLENEIMINE; POLYGLACTIN; RAF PROTEIN; RIBONUCLEASE H; SMALL INTERFERING RNA;

BASE PAIRING; CELL TRANSPORT; DNA MICROARRAY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG TARGETING; ELECTROPORATION; EXPRESSION VECTOR; FEMALE; GENE TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROMOLECULE; MALE; MICROINJECTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; REVIEW; RNA CLEAVAGE; RNA INTERFERENCE; RNA SEQUENCE; STRUCTURE ANALYSIS; THERMODYNAMICS;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 4644229437     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10611860400006257     Document Type: Review

References (166)

1. Akhtar, S. and Agrawal, S. (1997) "In vivo studies with antisense oligonucleotides", Trends Pharmacol. Sci. 18, 12-18.
2. Akhtar, S., Kole, R. and Juliano, R.L. (1991) "Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera", Life Sci. 49, 1793-1801.
3. Akhtar, S., Hughes, M.D., Khan, A., Double, J., Hussain, M., Nawaz, Q., Bibby, M. and Sayyed, P. (2000) "The delivery of antisense therapeutics", Adv. Drug Deliv. Rev. 44, 3-21.
4. Amarzguioui, M. and Prydz, H. (2004) "An algorithm for selection of functional siRNA sequences", Biochem. Biophys. Res. Commun. 316, 1050-1058.
5. Amarzguioui, M., Holen, T., Babaie, E. and Prydz, H. (2003) "Tolerance for mutations and chemical modifications in a siRNA" , Nucleic Acids Res. 31, 589-595.
6. Audouy, S.A., de Leij, L.F., Hoekstra, D. and Molema, G. (2002) "In vivo characteristics of cationic liposomes as delivery vectors for gene therapy", Pharm. Res. 19, 1599-1605.
7. Bai, X., Zhou, D., Brown, J.R., Crawford, B.E., Hennet, T. and Esko, J.D. (2001) "Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6)", J. Biol. Chem. 276, 48189-48195.
8. Bartel, D.P. (2004) "MicroRNAs: genomics, biogenesis, mechanism, and function", Cell 116, 281-297.
9. Bass, B.L. (2001) "RNA interference. The short answer", Nature 411, 428-429.
10. Beale, G., Hollins, A.J., Benboubetra, M., Sohail, M., Fox, S.P., Benter, I. and Akhtar, S. (2003) "Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system", J. Drug Target. 11, 449-456.
11. Boese, Q., Reynolds, A. and Marshall, W.A. (2004) "Basics of siRNA design and chemical synthesis", In: Sohail, M., ed., Gene Silencing by RNA Interference: Technology and Application (CRC press, Florida, USA), pp 15-35.
12. Bohula, E.A., Salisbury, A.J., Sohail, M., Playford, M.P., Riedemann, J., Southern, E.M. and Macaulay, V.M. (2003) "The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript", J. Biol. Chem. 278, 15991-15997.
13. Bose, A., Guilherme, A., Robida, S.I., Nicoloro, S.M., Zhou, Q.L., Jiang, Z.Y., Pomerleau, D.P. and Czech, M.P. (2002) "Glucose transporter recycling in response to insulin is facilitated by myosin Myolc", Nature 420, 821-824.
14. Boussif, O., Lezoualc'h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B. and Behr, J.P. (1995) "A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine", Proc. Natl Acad. Sci. USA 92, 7297-7301.
15. Braasch, D.A. and Corey, D.R. (2001) "Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA", Chem. Biol. 8, 1-7.
16. Braasch, D.A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M.A. and Corey, D.R. (2003) "RNA interference in mammalian cells by chemically-modified RNA", Biochemistry 42, 7967-7975.
17. Braasch, D.A., Paroo, Z., Constantinescu, A., Ren, G., Oz, O.K., Mason, R.P. and Corey, D.R. (2004) "Biodistribution of phosphodiester and phosphorothioate siRNA", Bioorg. Med. Chem. Lett. 14, 1139-1143.
18. Bridge, A.J., Pebernard, S., Ducraux, A., Nicoulaz, A.L. and Iggo, R. (2003) "Induction of an interferon response by RNAi vectors in mammalian cells", Nat. Genet. 34, 263-264.
19. Caplen, N.J. (2002) "A new approach to the inhibition of gene expression", Trends Biotechnol. 20, 49-51.
20. Capodici, J., Kariko, K. and Weissman, D. (2002) "Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference", J. Immunol. 169, 5196-5201.
21. Caudy, A.A., Myers, M., Hannon, G.J. and Hammond, S.M. (2002) "Fragile X-related protein and VIG associate with the RNA interference machinery", Genes Dev. 16, 2491-2496.
22. Caudy, A.A., Ketting, R.F., Hammond, S.M., Denli, A.M., Bathoorn, A.M., Tops, B.B., Silva, J.M., Myers, M.M., Hannon, G.J. and Plasterk, R.H. (2003) "A micrococcal nuclease homologue in RNAi effector complexes", Nature 425, 411-414.
23. Chi, J.T., Chang, H.Y., Wang, N.N., Chang, D.S., Dunphy, N. and Brown, P.O. (2003) "Genomewide view of gene silencing by small interfering RNAs", Proc. Natl Acad. Sci. USA 100, 6343-6346.
24. Chiu, Y.L. and Rana, T.M. (2002) "RNAi in human cells: basic structural and functional features of small interfering RNA", Mol. Cell 10, 549-561.
25. Chiu, Y.L. and Rana, T.M. (2003) "siRNA function in RNAi: a chemical modification analysis", RNA 9, 1034-1048.
26. Chung, H.K., Yi, Y.W., Jung, N.C., Kim, D., Suh, J.M., Kim, H., Park, K.C., Song, J.H., Kim, D.W., Hwang, E.S., Yoon, S.H., Bae, Y.S., Kim, J.M., Bae, I. and Shong, M. (2003) "CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle", J. Biol. Chem. 278, 28079-28088.
27. Coulson, J.M., Poyner, D.R., Chantry, A., Irwin, W.J. and Akhtar, S. (1996) "A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells", Mol. Pharmacol. 50, 314-325.
28. Czauderna, F., Fechtner, M., Dames, S., Aygun, H., Klippel, A., Pronk, G.J., Giese, K. and Kaufmann, J. (2003) "Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells", Nucleic Acids Res. 31, 2705-2716.
29. Dass, C.R. and Burton, M.A. (2003) "Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in-vivo", J. Pharm. Pharmacol. 55, 19-25.
30. Donze, O. and Picard, D. (2002) "RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase", Nucleic Acids Res. 30, e46.
31. Dorn, G., Patel, S., Wotherspoon, G., Hemmings-Mieszczak, M., Barclay, J., Natt, F.J., Martin, P., Bevan, S., Fox, A., Ganju, P., Wish M.W. and Hall, J. (2004) "siRNA relieves chronic neuropathic pain", Nucleic Acids Res. 32, e49.
32. Dorsett, Y. and Tuschl, T. (2004) "siRNAs: applications in functional genomics and potential as therapeutics", Nat. Rev. Drug Discov. 3, 318-329.
33. Drin, G., Cottin, S., Blanc, E., Rees, A.R. and Temsamani, J. (2003) "Studies on the internalization mechanism of cationic cell-penetrating peptides", J. Biol. Chem. 278, 31192-31201.
34. Duxbury, M.S., Ito, H., Benoit, E., Zinner, M.J., Ashley, S.W. and Whang, E.E. (2003) "RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity", Biochem. Biophys. Res. Commun. 311, 786-792.
35. Dykxhoorn, D.M., Novina, C.D. and Sharp, P.A. (2003) "Killing the messenger: short RNAs that silence gene expression", Nat. Rev. Mol. Cell Biol. 4, 457-467.
36. Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. and Tuschl, T. (2001a) "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells", Nature 411, 494-498.
37. Elbashir, S.M., Lendeckel, W. and Tuschl, T. (2001b) "RNA interference is mediated by 21- and 22-nucleotide RNAs", Genes Dev. 15, 188-200.
38. Elbashir, S.M., Martinez, J., Patkaniowska, A., Lendeckel, W. and Tuschl, T. (2001c) "Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate", EMBO J. 20, 6877-6888.
39. Elbashir, S.M., Harborth, J., Weber, K. and Tuschl, T. (2002) "Analysis of gene function in somatic mammalian cells using small interfering RNAs", Methods 26, 199-213.
40. Farhood, H., Bottega, R., Epand, R.M. and Huang, L. (1992) "Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity", Biochim. Biophys. Acta 1111, 239-246.
41. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L.L., Pepinsky, B. and Barsoum, J. (1994) "Tat-mediated delivery of heterologous proteins into cells", Proc. Natl Acad. Sci. USA 91, 664-668.
42. Fell, P.L., Hudson, A.J., Reynolds, M.A., Usman, N. and Akhtar, S. (1997) "Cellular uptake properties of a 2′-amino/2′-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA", Antisense Nucleic Acid Drug Dev. 7, 319-326.
43. Filion, M.C. and Phillips, N.C. (1997) "Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells", Biochim. Biophys. Acta 1329, 345-356.
44. Filleur, S., Courtin, A., Ait-Si-Ali, S., Guglielmi, J., Merle, C., Harel-Bellan, A., Clezardin, P. and Cabon, F. (2003) "SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth", Cancer Res. 63, 3919-3922.
45. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E. and Mello, C.C. (1998) "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", Nature 391, 806-811.
46. Fittipaldi, A., Ferrari, A., Zoppe, M., Arcangeli, C., Pellegrini, V., Beltram, F. and Giacca, M. (2003) "Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins", J. Biol. Chem. 278, 34141-34149.
47. Gaggar, A., Shayakhmetov, D.M. and Lieber, A. (2003) "CD46 is a cellular receptor for group B adenoviruses", Nat. Med. 9, 1408-1412.
48. Gan, L., Anton, K.E., Masterson, B.A., Vincent, V.A., Ye, S. and Gonzalez-Zulueta, M. (2002) "Specific interference with gene expression and gene function mediated by long dsRNA in neural cells" , J. Neurosci. Methods 121, 151-157.
49. Geary, R.S., Yu, R.Z. and Levin, A.A. (2001) "Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides", Curr. Opin. Investig. Drugs 2, 562-573.
50. Giladi, H., Ketzinel-Gilad, M., Rivkin, L., Felig, Y., Nussbaum, O. and Galun, E. (2003) "Small interfering RNA inhibits hepatitis B virus replication in mice", Mol. Ther 8, 769-776.
51. Haensler, J. and Szoka, F.C., Jr. (1993) "Polyamidoamine cascade polymers mediate efficient transfection of cells in culture" , Bioconjug. Chem. 4, 372-379.
52. Hall, J. (2004) "Unravelling the general properties of siRNAs strength in numbers and lessons from the past", Nat. Rev. Genet. 5, 552-557.
53. Hammond, S.M., Bernstein, E., Beach, D. and Hannon, G.J. (2000) "An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells", Nature 404, 293-296.
54. Hammond, S.M., Boettcher, S., Candy, A.A., Kobayashi, R. and Hannon, G.J. (2001) "Argonaute2, a link between genetic and biochemical analyses of RNAi", Science 293, 1146-1150.
55. Harborth, J., Elbashir, S.M., Vandenburgh, K., Manninga, H., Scaringe, S.A., Weber, K. and Tuschl, T. (2003) "Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing", Antisense Nucleic Acid Drug Dev. 13, 83-105.
56. Hohjoh, H. (2002) "RNA interference (RNA(i)) induction with various types of synthetic oligonucleotide duplexes in cultured human cells", FEBS Lett. 521, 195-199.
57. Holen, T., Amarzguioui, M., Wiiger, M.T., Babaie, E. and Prydz, H. (2002) "Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor", Nucleic Acids Res. 30, 1757-1766.
58. Hollins, A.J., Benboubetra, M., Omidi, Y., Zinselmeyer, B.H., Schatzlein, A.G., Uchegbu, I.F. and Akhtar, S. (2004) "Evaluation of generation 2 and 3 poly(propylenimine) dendrimers for the potential cellular delivery of antisense oligonucleotides targeting the epidermal growth factor receptor", Pharm. Res. 21, 458-466.
59. Huang, Y.Z., Zang, M., Xiong, W.C., Luo, Z. and Mei, L. (2003) "Erbin suppresses the MAP kinase pathway", J. Biol. Chem. 278, 1108-1114.
60. Huang, H., Zegarra-Moro, O.L., Benson, D. and Tindall, D.J. (2004) "Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells", Oncogene 23, 2161-2176.
61. Hudson, A.J., Normand, N., Ackroyd, J. and Akhtar, S. (1999) "Cellular delivery of hammerhead ribozymes conjugated to a transferrin receptor antibody", Int. J. Pharm. 182, 49-58.
62. Hughes, J., Astriab, A., Yoo, H., Alahari, S., Liang, E., Sergueev, D., Shaw, B.R. and Juliano, R.L. (2000) "In vitro transport and delivery of antisense oligonucleotides", Methods Enzymol. 313, 342-358.
63. Hughes, M.D., Hussain, M., Nawaz, Q., Petch, A.K., Sayyed, P. and Akhtar, S. (2001) "Cellular delivery of antisense oligonucleotides and ribozymes", Drug Discov. Today 6, 303-315.
64. Ishizuka, A., Siomi, M.C. and Siomi, H. (2002) "A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins", Genes Dev. 16, 2497-2508.
65. Islam, A., Handley, S.L., Thompson, K.S. and Akhtar, S. (2000) "Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems", J. Drug Target. 7, 373-382.
66. Jackson, A.L., Bartz, S.R., Schelter, J., Kobayashi, S.V., Burchard, J., Mao, M., Li, B., Cavet, G. and Linsley, P.S. (2003) "Expression profiling reveals off-target gene regulation by RNAi", Nat. Biotechnol. 21, 635-637.
67. Ji, J., Wernli, M., Klimkait, T. and Erb, P. (2003) "Enhanced gene silencing by the application of multiple specific small interfering RNAs", FEBS Lett. 552, 247-252.
68. Karmali, P.P., Kumar, V.V. and Chaudhuri, A. (2004) "Design, syntheses and in vitro gene delivery efficacies of novel mono-, di- and trilysinated cationic lipids: a structure-activity investigation", J. Med. Chem. 47, 2123-2132.
69. Kawasaki, A.M., Casper, M.D., Freier, S.M., Lesnik, E.A., Zounes, M.C., Cummins, L.L., Gonzalez, C. and Cook, P.D. (1993) "Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets", J. Med. Chem. 36, 831-841.
70. Kennedy, S., Wang, D. and Ruvkun, G. (2004) "A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans", Nature 427, 645-649.
71. Kennerdell, J.R. and Carthew, R.W. (1998) "Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway", Cell 95, 1017-1026.
72. Khan, A., Sommer, W., Fuxe, K. and Akhtar, S. (2000) "Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain", J. Drug Target. 8, 319-334.
73. Khan, A., Benboubetra, M., Wooi, K.N., Fox, S., Beck, G. and Akhtar, S. (2004) "Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies", J. Drug Target., in press.
74. Khvorova, A., Reynolds, A. and Jayasena, S.D. (2003) "Functional siRNAs and miRNAs exhibit strand bias", Cell 115, 209-216.
75. Kretschmer-Kazemi Far, R. and Sczakiel, G. (2003) "The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides", Nucleic Acids Res. 31, 4417-4424.
76. Krichevsky, A.M. and Kosik, K.S. (2002) "RNAi functions in cultured mammalian neurons", Proc. Natl Acad. Sci. USA 99, 11926-11929.
77. Kumar, R., Conklin, D.S. and Mittal, V. (2003) "High-throughput selection of effective RNAi probes for gene silencing", Genome Res. 13, 2333-2340.
78. Laposa, R.R., Feeney, L. and Cleaver, J.E. (2003) "Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H", Cancer Res. 63, 3909-3912.
79. Lee, J.C., Schickling, O., Stegh, A.H., Oshima, R.G., Dinsdale, D., Cohen, G.M. and Peter, M.E. (2002) "DEDD regulates degradation of intermediate filaments during apoptosis", J. Cell Biol. 158, 1051-1066.
80. Leirdal, M. and Sioud, M. (2002) "Gene silencing in mammalian cells by preformed small RNA duplexes", Biochem. Biophys. Res. Commun. 295, 744-748.
81. Len, Y.W., Rahmatpanah, F., Shi, H., Wei, S.H., Liu, J.C., Yan, P.S. and Huang, T.H. (2003) "Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation", Cancer Res. 63, 6110-6115.
82. Lewis, K.J., Irwin, W.J. and Akhtar, S. (1998) "Development of a sustained-release biodegradable polymer system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro", J. Drug Target. 5, 291-302.
83. Lewis, D.L., Hagstrom, J.E., Loomis, A.G., Wolff, J.A. and Herweijer, H. (2002) "Efficient delivery of siRNA for inhibition of gene expression in postnatal mice", Nat. Genet. 32, 107-108.
84. Lieberman, J., Song, E., Lee, S.K. and Shankar, P. (2003) "Interfering with disease: opportunities and roadblocks to harnessing RNA interference", Trends Mol. Med. 9, 397-403.
85. Lindgren, M., Hallbrink, M., Prochiantz, A. and Langel, U. (2000) "Cell-penetrating peptides", Trends Pharmacol. Sci. 21, 99-103.
86. Lingel, A., Simon, B., Izaurralde, E. and Sattler, M. (2003) "Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain", Nature 426, 465-469.
87. Liu, Q., Rand, T.A., Kalidas, S., Du, F., Kim, H.E., Smith, D.P. and Wang, X. (2003) "R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway", Science 301, 1921-1925.
88. Loke, S.L., Stein, C., Zhang, X., Avigan, M., Cohen, J. and Neckers, L.M. (1988) "Delivery of c-myc antisense phosphorothioate oligodeoxy-nucleotides to hematopoictic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis", Curr. Top. Microbiol. Immunol. 141, 282-289.
89. Lundberg, P. and Langel, U. (2003) "A brief introduction to cell-penetrating peptides", J. Mol. Recognit. 16, 227-233.
90. Luo, K.Q. and Chang, D.C. (2004) "The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted region", Biochem. Biophys. Res. Commun. 318, 303-310.
91. Makimura, H., Mizuno, T.M., Mastaitis, J.W., Agami, R. and Mobbs, C.V. (2002) "Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake", BMC Neurosci. 3, 18.
92. Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R. and Tuschl, T. (2002) "Single-stranded antisense siRNAs guide target RNA cleavage in RNAi", Cell 110, 563-574.
93. Martinez, J. and Tuschl, T. (2004) "RISC is a 5′ phosphomonoester-producing RNA endonuclease", Genes Dev. 18, 975-980.
94. Massaro, D., Massaro, G.D. and Clerch, L.B. (2004) "Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice", Am. J. Physiol. Lung Cell. Mol. Physiol., in press.
95. Mathews, D.H., Sabina, J., Zuker, M. and Turner, D.H, (1999) "Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure", J. Mol. Biol. 288, 911-940.
96. Maurer-Stroh, S., Dickens, N.J., Hughes-Davies, L., Kouzarides, T., Eisenhaber, F. and Pouting, C.P. (2003) "The Tudor domain Royal Family: Tudor, plant Agenet, Chromo, PWWP and MBT domains", Trends Biochem. Sci. 28, 69-74.
97. McCaffrey, A.P., Meuse, L., Pham, T.T., Conklin, D.S., Hannon, G.J. and Kay, M.A. (2002) "RNA interference in adult mice", Nature 418, 38-39.
98. McManus, M.T. and Sharp, P.A. (2002) "Gene silencing in mammals by small interfering RNAs", Nat. Rev. Genet. 3, 737-747.
99. McManus, M.T., Haines, B.B., Dillon, C.P., Whitehurst, C.E., van Parijs, L., Chen, J. and Sharp, P.A. (2002) "Small interfering RNA-mediated gene silencing in T lymphocytes", J. Immunol. 169, 5754-5760.
100. Medema, R.H. (2004) "Optimizing RNA interference for application in mammalian cells", Biochem. J., in press.
101. Miyagishi, M., Matsumoto, S. and Taira, K. (2004) "Generation of an shRNAi expression library against the whole human transcripts", Virus Res. 102, 117-124.
102. Mohmmed, A., Dasaradhi, P.V., Bhatnagar, R.K., Chauhan, V.S. and Malhotra, P. (2003) "In vivo gene silencing in Plasmodium berghei - a mouse malaria model", Biochem. Biophys. Res. Commun. 309, 506-511.
103. Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J., Kawasaki, A.M., Cook, P.D. and Freier, S.M. (1993) "Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression", J. Biol. Chem. 268, 14514-14522.
104. Monia, B.P., Johnston, J.F., Geiger, T., Muller, M. and Fabbro, D. (1996) "Antitumor activity of a phosphorothioate antisense oligodeoxy-nucleotide targeted against C-raf kinase", Nat. Med. 2, 668-675.
105. Morris, M.C., Vidal, P., Chaloin, L., Heitz, F. and Divita, G. (1997) "A new peptide vector for efficient delivery of oligonucleotides into mammalian cells", Nucleic Acids Res. 25, 2730-2736.
106. Morris, M.C., Chaloin, L., Mery, J., Heitz, F. and Divita, G. (1999) "A novel potent strategy for gene delivery using a single peptide vector as a carrier", Nucleic Acids Res. 27, 3510-3517.
107. Muratovska, A. and Eccles, M.R. (2004) "Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells", FEBS Lett. 558, 63-68.
108. Nagahiro, I., Mora, B.N., Boasquevisque, C.H., Scheule, R.K. and Patterson, G.A. (2000) "Toxicity of cationic liposome-DNA complex in lung isografts", Transplantation 69, 1802-1805.
109. Nikcevic, G., Kovacevic-Grujicic, N. and Stevanovic, M. (2003) "Improved transfection efficiency of cultured human cells", Cell Biol. Int. 27, 735-737.
110. North, B.J., Marshall, B.L., Borra, M.T., Denu, J.M. and Verdin, E. (2003) "The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase", Mol. Cell 11, 437-444.
111. Nykanen, A., Haley, B. and Zamore, P.D. (2001) "ATP requirements and small interfering RNA structure in the RNA interference pathway", Cell 107, 309-321.
112. Oelgeschlager, M., Larrain, J., Geissert, D. and De Robertis, E.M. (2000) "The evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling", Nature 405, 757-763.
113. Omidi, Y., Hollins, A.J., Benboubetra, M., Drayton, R., Benter, I.F. and Akhtar, S. (2003) "Toxicogenomics of non-viral vectors for gene therapy: a microarray study of lipofectin- and oligofectamine-induced gene expression changes in human epithelial cells", J. Drug Target. 11, 311-323.
114. Parrish, S., Fleenor, J., Xu, S., Mello, C. and Fire, A. (2000) "Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference", Mol. Cell 6, 1077-1087.
115. Pedroso de Lima, M.C., Simoes, S., Pires, P., Faneca, H. and Duzgunes, N. (2001) "Cationic lipid-DNA complexes in gene delivery: from biophysics to biological applications", Adv. Drug Deliv. Rev. 47, 277-294.
116. Persengiev, S.P., Zhu, X. and Green, M.R. (2004) "Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs)", RNA 10, 12-18.
117. Petch, A.K., Sohail, M., Hughes, M.D., Benter, I., Darling, J., Southern, E.M. and Akhtar, S. (2003) "Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides", Biochem. Pharmacol. 66, 819-830.
118. Pham, J.W., Pellino, J.L., Lee, Y.S., Carthew, R.W. and Sontheimer, E.J. (2004) "A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila", Cell 117, 83-94.
119. Pleyer, U., Groth, D., Hinz, B., Keil, O., Bertelmann, E., Rieck, P. and Reszka, R. (2001) "Efficiency and toxicity of liposome-mediated gene transfer to corneal endothelial cells", Exp. Eye Res. 73, 1-7.
120. Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J.X., Xu, X.J., Wiesenfeld-Hallin, Z., Hokfelt, T., Bartfai, T. and Langel, U. (1998) "Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo", Nat. Biotechnol. 16, 857-861.
121. Porter, L.A., Dellinger, R.W., Tynan, J.A., Barnes, E.A., Kong, M., Lenormand, J.L. and Donoghue, D.J. (2002) "Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2", J. Cell Biol. 157, 357-366.
122. Potente, M., Fisslthaler, B., Busse, R. and Fleming, I. (2003) "11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1", J. Biol. Chem. 278, 29619-29625.
123. Puebla, I., Esseghir, S., Mortlock, A., Brown, A., Crisanti, A. and Low, W. (2003) "A recombinant H1 histone-based system for efficient delivery of nucleic acids", J. Biotechnol. 105, 215-226.
124. Reich, S.J., Fosnot, J., Kuroki, A., Tang, W., Yang, X., Maguire, A.M., Bennett, J. and Tolentino, M.J. (2003) "Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model", Mol. Vis. 9, 210-216.
125. Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W.S. and Khvorova, A. (2004) "Rational siRNA design for RNA interference", Nat. Biotechnol. 22, 326-330.
126. Richard, J.P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M.J., Chernomordik, L.V. and Lebleu, B. (2003) "Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake", J. Biol. Chem. 278, 585-590.
127. Rockwell, P., O'Connor, W.J., King, K., Goldstein, N.I., Zhang, L.M. and Stein, C.A. (1997) "Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides", Proc. Natl Acad. Sci. USA 94, 6523-6528.
128. Sands, H., Gorey-Feret, L.J., Cocuzza, A.J., Hobbs, F.W., Chidester, D. and Trainor, G.L. (1994) "Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate", Mol. Pharmacol. 45, 932-943.
129. Schiffelers, R.M., Woodle, M.C. and Scaria, P. (2004) "Pharmaceutical prospects for RNA interference", Pharm. Res. 21, 1-7.
130. Schwarz, D.S., Hutvagner, G., Haley, B. and Zamore, P.D. (2002) "Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways", Mol. Cell 10, 537-548.
131. Schwarz, D.S., Hutvagner, G., Du, T., Xu, Z., Aronin, N. and Zamore, P.D. (2003) "Asymmetry in the assembly of the RNAi enzyme complex", Cell 115, 199-208.
132. Schwarz, D.S., Tomari, Y. and Zamore, P.D. (2004) "The RNA-induced silencing complex is a Mg2+-dependent endonuclease", Curr. Biol. 14, 787-791.
133. Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D.N. and Fesik, S.W. (2003) "Specificity of short interfering RNA determined through gene expression signatures", Proc. Natl Acad. Sci. USA 100, 6347-6352.
134. Shoji, Y., Akhtar, S., Periasamy, A., Herman, B. and Juliano, R.L. (1991) "Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages", Nucleic Acids Res. 19, 5543-5550.
135. Simeoni, F., Morris, M.C., Heitz, F. and Divita, G. (2003) "Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells" , Nucleic Acids Res. 31, 2717-2724.
136. Sioud, M. (2004) "Therapeutic siRNAs", Trends Pharmacol. Sci. 25, 22-28.
137. Sledz, C.A., Holko, M., de Veer, M.J., Silverman, R.H. and Williams, B.R. (2003) "Activation of the interferon system by short-interfering RNAs", Nat. Cell Biol. 5, 834-839.
138. Smith, L., Andersen, K.B., Hovgaard, L. and Jaroszewski, J.W. (2000) "Rational selection of antisense oligonucleotide sequences", Eur. J. Pharm. Sci. 11, 191-198.
139. Sohail, M. and Southern, E.M. (2000) "Selecting optimal antisense reagents", Adv. Drug Deliv. Rev. 44, 23-34.
140. Sohail, M., Hochegger, H., Klotzbucher, A., Guellec, R.L., Hunt, T. and Southern, E.M. (2001) "Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo", Nucleic Acids Res. 29, 2041-2051.
141. Song, E., Lee, S.K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P. and Lieberman, J. (2003a) "RNA interference targeting Fas protects mice from fulminant hepatitis", Nat. Med. 9, 347-351.
142. Song, J.J., Liu, J., Tolia, N.H., Schneiderman, J., Smith, S.K., Martienssen, R.A., Hannon, G.J. and Joshua-Tor, L. (2003b) " The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes", Nat. Struct. Biol. 10, 1026-1032.
143. Sorensen, D.R., Leirdal, M. and Sioud, M. (2003) "Gene silencing by systemic delivery of synthetic siRNAs in adult mice", J. Mol. Biol. 327, 761-766.
144. Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H. and Schreiber, R.D. (1998) "How cells respond to interferons", Annu. Rev. Biochem. 67, 227-264.
145. Tarahovsky, Y.S. and Ivanitsky, G.R. (1998) "Structural polymorphism of lipids and effectiveness of gene delivery", Biochemistry (Mosc) 63, 607-618.
146. Theobald, D.L., Mitton-Fry, R.M. and Wuttke, D.S. (2003) "Nucleic acid recognition by OB-fold proteins", Annu. Rev. Biophys. Biomol. Struct. 32, 115-133.
147. Theodore, L., Derossi, D., Chassaing, G., Llirbat, B., Kubes, M., Jordan, P., Chneiweiss, H., Godement, P. and Prochiantz, A. (1995) "Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse", J. Neurosci. 15, 7158-7167.
148. Tijsterman, M., Ketting, R.F. and Plasterk, R.H. (2002) "The genetics of RNAsilencing", Annu. Rev. Genet. 36, 489-519.
149. Tolentino, M.J., Brucker, A.J., Fosnot, J., Ying, G.S., Wu, I.H., Malik, G., Wan, S. and Reich, S.J. (2004) "Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization", Retina 24, 132-138.
150. Torchilin, V.P., Rammohan, R., Weissig, V. and Levchenko, T.S. (2001) "TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors", Proc. Natl Acad. Sci. USA 98, 8786-8791.
151. Troussard, A.A., Mawji, N.M., Ong, C., Mui, A., St -Arnaud, R. and Dedhar, S. (2003) "Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation", J. Biol. Chem. 278, 22374-22378.
152. Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H. and Sabe, H. (2002) "Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration", J. Cell Biol. 159, 673-683.
153. Ui-Tei, K., Naito, Y., Takahashi, F., Haraguchi, T., Ohki-Hamazaki, H., Juni, A., Ueda, R. and Saigo, K. (2004) " Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference", Nucleic Acids Res. 32, 936-948.
154. Usui, I., Imamura, T., Huang, J., Satoh, H. and Olefsky, J.M. (2003) "Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes", J. Biol. Chem. 278, 13765-13774.
155. Verma, U.N., Surabhi, R.M., Schmaltieg, A., Becerra, C. and Gaynor, R.B. (2003) "Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells", Clin. Cancer Res. 9, 1291-1300.
156. Vickers, T.A., Koo, S., Bennett, C.F., Crooke, S.T., Dean, N.M. and Baker, B.F. (2003) "Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis", J. Biol. Chem. 278, 7108-7118.
157. Whitehouse, A. (2003) "Herpesvirus saimiri: a potential gene delivery vector (review)", Int. J. Mol. Med. 11, 139-148.
158. Wickstrom, E. (1986) "Oligodeoxynucleotide stability in subcellular extracts and culture media", J. Biochem. Biophys. Methods 13,97-102.
159. Williams, S.A. and Buzby, J.S. (2000) "Cell-specific optimization of phosphorothioate antisense oligodeoxynucleotide delivery by cationic lipids", Methods Enzymol. 313, 388-397.
160. Xu, Y., Zhang, H.Y., Thormeyer, D., Larsson, O., Du, Q., Elmen, J., Wahlestedt, C. and Liang, Z. (2003) "Effective small interfering RNAs and phosphorothioate antisense DNAs have different preferences for target sites in the luciferase mRNAs", Biochem. Biophys. Res. Commun. 306, 712-717.
161. Yang, D., Buchholz, F., Huang, Z., Goga, A., Chen, C.Y., Brodsky, F.M. and Bishop, J.M. (2002) "Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells", Proc. Natl Acad. Sci. USA 99, 9942-9947.
162. Yoon, H.S., Chen, X. and Yang, V.W. (2003) "Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage", J. Biol. Chem. 278, 2101-2105.
163. Zamore, P.D., Tuschl, T., Sharp, P.A. and Bartel, D.P. (2000) "RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals", Cell 101, 25-33.
164. Zender, L., Hutker, S., Liedtke, C., Tillmann, H.L., Zender, S., Mundt, B., Waltemathe, M., Gosling, T., Flemming, P., Malek, N.P., Trautwein, C., Manns, M.P., Kuhnel, F. and Kubicka, S. (2003) " Caspase 8 small interfering RNA prevents acute liver failure in mice" , Proc. Natl Acad. Sci. USA 100, 7797-7802.
165. Zhang, D., Li, F., Weidner, D., Mnjoyan, Z.H. and Fujise, K. (2002) "Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone", J. Biol. Chem. 277, 37430-37438.
166. Zhang, X., Shan, P., Jiang, D., Noble, P.W., Abraham, N.G., Kappas, A. and Lee, P.J. (2004) "Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis", J. Biol. Chem. 279, 10677-10684.